3B BlackBio DX Complete Financial Statements
In FY2025, 3B BlackBio DX (3BBLACKBIO) reported revenue ₹39 Cr, net profit ₹15 Cr and EPS ₹17.55, with a net profit margin of 38.5% and ROE of 5.5%. Full financial statements from FY2011 to FY2025 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see 3B BlackBio DX stock price NSE .
12 Years of Data
2025 - 2011
Complete Financial Data Export
Profitability Ratios
Net Profit Margin
38.46%
2025 data
EBITDA Margin
51.28%
2025 data
Operating Margin
43.00%
2025 data
Return on Assets
5.07%
2025 data
Return on Equity
5.54%
2025 data
Balance Sheet Ratios
Current Ratio
22.00
2025 data
Equity Ratio
91.55%
2025 data
Asset Turnover
0.13
2025 data
3BBLACKBIO Revenue, Net Profit & EBITDA — Year-on-Year Growth
3BBLACKBIO YoY (Sept 2024 vs Sept 2025) — revenue +18.2%, expenses +46.2%.
Revenue Growth
+18.2%
Year-over-Year
Expense Growth
+46.2%
Year-over-Year
Assets Growth
+19.4%
Year-over-Year
Equity Growth
+19.9%
Year-over-Year
Operating Cash Flow Growth
+59.3%
Year-over-Year
Investing Cash Flow Growth
-70.0%
Year-over-Year
Financing Cash Flow Growth
+25.0%
Year-over-Year
3BBLACKBIO Income Statement — Revenue, EBITDA & Net Profit
3B BlackBio DX revenue ₹39 Cr, EBITDA ₹20 Cr, net profit ₹15 Cr, EPS ₹17.55 (2025) — net profit margin 38.5%. Explore 3B BlackBio DX intrinsic worth to estimate fundamental worth using multiple valuation models.
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 | Mar 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39 | 27 | 27 | 56 | 33 | 27 | 23 | 28 | 22 | 19 | 17 | 20 | 19 | 20 | 13 | 18 | 17 | 20 | 34 | 16 | 112 | 8 | 53 | 44 | 10 | 6 | 6 | 7 | 8 | 5 | 4 | 6 | 8 | 3 | 4 | 6 | 6 | 5 | 3 | 4 | 6 | 6 | 3 | 5 | 2 |
| Expenses | 19 | 15 | 10 | 29 | 13 | 13 | 9 | 10 | 11 | 11 | 8 | 9 | 8 | 13 | 7 | 7 | 9 | 10 | 15 | 7 | 32 | 4 | 17 | 18 | 7 | 4 | 3 | 5 | 6 | 4 | 3 | 4 | 6 | 3 | 3 | 4 | 5 | 4 | 2 | 4 | 5 | 6 | 3 | 4 | 2 |
| EBITDA | 20 | 13 | 16 | 27 | 20 | 14 | 15 | 18 | 11 | 9 | 9 | 12 | 11 | 8 | 6 | 10 | 8 | 10 | 20 | 9 | 80 | 3 | 37 | 27 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Operating Profit Margin % | 43.00% | 35.00% | 53.00% | 43.00% | 56.00% | 43.00% | 56.00% | 59.00% | 41.00% | 41.00% | 45.00% | 50.00% | 53.00% | 32.00% | 44.00% | 50.00% | 39.00% | 45.00% | 56.00% | 49.00% | 71.00% | 35.00% | 69.00% | 58.00% | 25.00% | 38.00% | 39.00% | 34.00% | 23.00% | 24.00% | 34.00% | 32.00% | 23.00% | 16.00% | 26.00% | 21.00% | 19.00% | 5.00% | 16.00% | 12.00% | 10.00% | 2.00% | 6.00% | 12.00% | 16.00% |
| Depreciation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 20 | 13 | 16 | 27 | 19 | 14 | 14 | 18 | 10 | 8 | 9 | 11 | 11 | 8 | 6 | 10 | 8 | 10 | 20 | 8 | 80 | 3 | 36 | 26 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 5 | 5 | 3 | 4 | 4 | 5 | 3 | 4 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 2 | 20 | 1 | 9 | 7 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 15 | 8 | 13 | 22 | 15 | 9 | 11 | 14 | 8 | 5 | 7 | 9 | 8 | 5 | 5 | 8 | 6 | 7 | 15 | 7 | 60 | 2 | 27 | 20 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 17.55 | 9.38 | 14.76 | 26.19 | 17.35 | 10.26 | 13.19 | 15.75 | 8.86 | 6.94 | 8.41 | 9.94 | 9.70 | 6.43 | 6.28 | 9.00 | 6.84 | 9.47 | 19.89 | 8.74 | 79.56 | 3.02 | 36.22 | 26.20 | 3.00 | 1.94 | 1.89 | 2.31 | 2.39 | 0.91 | 1.37 | 2.48 | 2.07 | 0.15 | 1.04 | 1.32 | 1.11 | -0.39 | 0.06 | 0.30 | 0.47 | -0.39 | -0.15 | 0.42 | 0.00 |
3BBLACKBIO Balance Sheet — Assets, Liabilities & Shareholders' Equity
3BBLACKBIO total assets ₹296 Cr, total equity ₹271 Cr, total liabilities ₹ Cr (2025) — ROE 5.5%.
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 296 | 248 | 214 | 192 | 194 | 45 | 36 | 30 | 26 | 24 | 25 |
| Current Assets | 132 | 123 | 114 | 82 | 118 | 39 | 32 | 26 | 22 | 21 | 21 |
| Fixed Assets | 7 | 7 | 8 | 7 | 5 | 4 | 4 | 4 | 3 | 3 | 4 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 156 | 117 | 92 | 93 | 59 | 1 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 132 | 123 | 115 | 93 | 130 | 40 | 32 | 27 | 22 | 21 | 21 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 6 | 5 | 4 | 3 | 2 | 2 | 3 | 3 | 4 | 3 | 3 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 271 | 226 | 196 | 172 | 148 | 34 | 23 | 19 | 11 | 10 | 10 |
| Share Capital | 9 | 9 | 9 | 8 | 8 | 8 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 260 | 215 | 185 | 146 | 125 | 25 | 16 | 12 | 5 | 4 | 4 |
3BBLACKBIO Cash Flow Statement — Operating, Investing & Financing
3B BlackBio DX operating cash flow ₹43 Cr, investing ₹-34 Cr, financing ₹-3 Cr, net cash flow ₹7 Cr (2025).
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 43 | 27 | 20 | 37 | 98 | 7 | 4 | 2 | 1 | 1 | 0 |
| Investing Activities | -34 | -20 | 15 | -28 | -70 | -1 | -1 | -1 | 0 | 0 | 0 |
| Financing Activities | -3 | -4 | -5 | -15 | -2 | 1 | -1 | 0 | 0 | -1 | 0 |
| Net Cash Flow | 7 | 3 | 30 | -6 | 26 | 7 | 2 | 1 | 0 | 0 | 0 |